BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4286382)

  • 21. [Stimulation of DPN metabolic processes in ascites tumors by low dosage roentgen irradiation and trenimon].
    Rüter J; Vachek H; Oldekop M; Wüppen I; Hilz H
    Biochem Z; 1966 Mar; 344(2):153-66. PubMed ID: 4293039
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of the alkylating agent trisethyleneiminobenzoquinone (trenimon) on the template activity of chromatin and DNA in RNA and DNA polymerase systems.
    Puschendorf B; Wolf H; Grunicke H
    Biochem Pharmacol; 1971 Nov; 20(11):3039-50. PubMed ID: 4943597
    [No Abstract]   [Full Text] [Related]  

  • 23. Depression of the intracellular histone messenger RNA content by the alkylating agent 2,3,5-trisethyleneiminobenzoquinone.
    Raydt G; Holzweber F; Puschendorf B; Grunicke H
    FEBS Lett; 1977 Feb; 74(1):111-4. PubMed ID: 838068
    [No Abstract]   [Full Text] [Related]  

  • 24. Proceedings: Effect of triethyleneiminobenzoquinone (trenimon) on thymidine transport in Ehrlich ascites tumor cells.
    Hirsch F; Wolf H; Grunicke H
    Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1208. PubMed ID: 4477748
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of isoniazid on preservation of nicotinamide dinucleotide in animal cells.
    Bekierkunst A
    Arch Biochem Biophys; 1967 Mar; 118(3):549-55. PubMed ID: 4292711
    [No Abstract]   [Full Text] [Related]  

  • 26. [The influence of Trenimon (2,3,5-tris-ethyleneimino-benzoquinone-1,4) on the content of free nicotinic acid and free nicotinamide in Ehrlich ascites tumor cells].
    Fussgänger R; Dold U; Holzer H
    Z Krebsforsch; 1967; 69(3):275-82. PubMed ID: 4233246
    [No Abstract]   [Full Text] [Related]  

  • 27. [Influence of cytostatic agents on proteolytic enzymes of human ovary].
    Wagner F; Koob G; Hofmann KD; Preibsch W; Niedner W; Strohbach H
    Zentralbl Gynakol; 1973 Feb; 95(8):253-8. PubMed ID: 4697128
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modifications of mucosa of the small intestine in patients subjected to antimitotic treatment].
    De Dominicis R; Melani FM; Giannardi GF; Maijnelli M
    Minerva Radiol; 1965; 10(7):290-1. PubMed ID: 5844623
    [No Abstract]   [Full Text] [Related]  

  • 29. [In vivo studies on the effect of Trenimon (II). Comparison of Ehrlich ascites tumor cells and normal tissue].
    Liss E; Palme G; Oeff K
    Z Krebsforsch; 1968; 71(1):98-101. PubMed ID: 4233402
    [No Abstract]   [Full Text] [Related]  

  • 30. [The studies on anerobic glycolysis and the inhibition of lactic acid production in Ehrlich's ascites carcinoma by anticancer agents].
    Koga H
    Kumamoto Igakkai Zasshi; 1971 Feb; 45(2):169-99. PubMed ID: 5109085
    [No Abstract]   [Full Text] [Related]  

  • 31. Depression of histone acetylation by alkylating antitumor agents in murine cells.
    Zwierzina H; Loidl A; Fuith LC; Helliger W; Puschendorf B; Grunicke H
    Cancer Res; 1984 Aug; 44(8):3336-9. PubMed ID: 6744267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of mechlorethamine and cyclophosphamide on the nicotinamide-adenine dinucleotide glycohydrolase activity in Ehrlich ascites cells and L1210 leukemia cells.
    Fraser I
    Proc West Pharmacol Soc; 1965; 8():61-3. PubMed ID: 4285800
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of Novurit on the glycolysis of Ehrlich ascites carcinoma cells].
    Fejete I; Serfözö JI
    Naturwissenschaften; 1965 Oct; 52(19):541. PubMed ID: 5882854
    [No Abstract]   [Full Text] [Related]  

  • 34. [Differenciation of reaction mechanisms of alkylating cytostatics on Ehrlich ascites-carcinoma- and lymphatic leucemic cells].
    Kummer D; Ochs HD
    Z Krebsforsch; 1970 Mar; 73(4):315-28. PubMed ID: 4245611
    [No Abstract]   [Full Text] [Related]  

  • 35. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV; Eremeeva AA; Tereshin IM
    Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of hyperbaric oxygenation on the anticancer effect of alkylating agents (endoxan and mitomycin-C).
    Miyamoto Y
    Kumamoto Med J; 1968 Sep; 21(3):108-13. PubMed ID: 5708370
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action of ethyleniminoquinones on the growth and cellular respiration of human tissue culture strains].
    Rizzoli C; Simonelli L
    Boll Soc Ital Biol Sper; 1964 Feb; 40(3):122-4. PubMed ID: 5875771
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of hydroxyurea and trisethyleneiminobenzoquinone (Trenimon) on the methylation of DNA in Ehrlich ascites tumor cells.
    Puschendorf B; Grunicke H
    Biochim Biophys Acta; 1972 Jun; 272(1):16-21. PubMed ID: 5043710
    [No Abstract]   [Full Text] [Related]  

  • 39. Glycolytic mechanisms in Ehrlich ascites tumor cells-effects of disulfide derivatives of pyridine.
    Poole DT; Butler TC; Williams ME
    Biochem Pharmacol; 1973 Aug; 22(15):1893-904. PubMed ID: 4352919
    [No Abstract]   [Full Text] [Related]  

  • 40. Mode of action of anticancer agents on iron metabolism in tumor-bearing mice. II. A possible mechanism for potentiation of the carcinostatic activity of alkylating agents by ferrous glucuronate.
    Hano K; Akashi A
    Gan; 1965 Aug; 56(4):385-402. PubMed ID: 4954025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.